Release Date: 06/10/15 11:19 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 278.76KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%